Alnylam Licenses RNAi Patent Family to Qiagen

Sep 21, 2005

NEW YORK, Sept. 21 (GenomeWeb News) - Qiagen has licensed a number of RNA interference patents from Alnylam Pharmaceuticals, Alnylam said today.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.